Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
On Jan. 19, 2016, the McDonnell Genome Institute at Washington University School of Medicine in St. Louis announced…
On Jul. 14, 2015, Benaroya Research Institute at Virginia Mason (BRI) announced that Carla J. Greenbaum, MD, had…
On Dec. 23, 2014, Novo Nordisk the FDA approved a formulation of Novo Nordiskï¾’s diabetes drug, liraglutide, for…
On Oct. 15, 2014, the University of Iowa ushered in a new age of accelerated research in biomedicine…
On Oct. 9, 2014, a landmark study led by Douglas Melton from Harvard University successfully generated functional, mature human…
On Sept. 3, 2014, Abbott announced it had received CE Mark (Conformite Europeenne) for its FreeStyleï¾® Libre Flash…
On Jun. 28, 2014, The Burnham Institute for Medical Research announced a record $275 million anonymous to helping…
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
On Aug. 6, 2013, Pacific Northwest Diabetes Research Institute (PNDRI) received a $2 million National Institutes of Health…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
On Sept. 15, 2010, Pacific Northwest Diabetes Research Institute appointed Jack Faris, Ph.D., as Chief Executive Officer. Previously,…
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
On Sept. 16, 2008, leaders of The Fraternal Order of Eagles, the University of Iowa and the University…
On Feb 25, 2008, the Pacific Northwest Research Institute changed its name to Pacific Northwest Diabetes Research Institute…
On Jul. 11, 2007, Oregon Health & Science University (OHSU) announced a leadership gift of $5.5 million from…
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
In 2006, Texas Biomed researchers published a genetic linkage map for the rhesus monkey. In 1999, Texas Biomed…
On Apr. 29, 2005, Amylin Pharmaceuticals and Eli Lilly announced the FDA had approved BYETTA(TM) (exenatide) injection as…
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
In 2004, the OMRF opened the state’s first small animal magnetic resonance imaging facility. It is one of…
On Apr. 23, 2003, Dr. Vincent Poitout at the Pacific Northwest Research Foundation (PNRF) won the Thomas R….
On Apr. 2, 2003, the Virginia Mason Research Center, located in Seattle, was renamed Benaroya Research Institute at…
In 2003, Dr. William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study….
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…